Bevacizumab in the treatment of ovarian cancer
Neyt M, Devriese S, Camberlin C, Vlayen J
Record ID 32007000822
English
Details
Project Status:
Completed
URL for project:
https://www.kce.fgov.be/en/publication/report/bevacizumab-in-the-treatment-of-ovarian-cancer
Year Published:
2017
URL for published report:
https://www.kce.fgov.be/en/publication/report/bevacizumab-in-the-treatment-of-ovarian-cancer
URL for additional information:
https://www.kce.fgov.be/en/publication/report/bevacizumab-in-the-treatment-of-ovarian-cancer
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Belgium
MeSH Terms
- Angiogenesis Inhibitors
- Vascular Endothelial Growth Factor A
- Bevacizumab
- Ovarian Neoplasms
Contact
Organisation Name:
Belgian Health Care Knowledge Centre
Contact Address:
Administrative Centre Botanique, Doorbuilding (10th floor), Boulevard du Jardin Botanique 55, B-1000 Brussels, Belgium tel: +32 2 287 33 88 fax: +32 2 287 33 85
Contact Name:
info@kce.fgov.be
Contact Email:
info@kce.fgov.be
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.